10 completed, 2 active not recruiting. 5 Phase 2, 4 Phase 1, 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Active not recruiting 1 |
| Phase 1 | 4 | Completed 4 |
| Early Phase 1 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Smallpox Vaccine: new trials by email Literature Review of Smallpox Vaccine trials Research Report on Smallpox Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Human Immune Response to the JYNNEOS Vaccine JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) suspension for subcutaneous injection, Phlebotomy, Research bronchoscopy - Vaccinia, Virus Diseases | Early Phase 1 | Active not recruiting | Washington University School of Medicine | 20 | 2024-06-10 | 2026-10-21 |
| Break-through Infection Following Mpox vaccinatIon Mpox Vaccine - Mpox | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 3125 | 2022-09-12 | 2024-06-06 | |
| Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS Tecovirimat, Smallpox and Mpox Vaccine, Placebo - Smallpox | Phase 2 | Active not recruiting | SIGA Technologies | 100 | 2022-04-05 | 2026-09-14 |
| Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years VAC∆6 vaccine - оnce at a dose of 10⁶ PFU, VAC∆6 vaccine - once at a dose of 10⁷ PFU, VAC∆6 vaccine - twice at a dose of 10⁶ PFU - Smallpox, Monkeypox | Phase 1 | Completed | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 60 | 2019-05-18 | 2023-03-09 |
| Pilot-RCT With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder Homoeopathic medicines, Placebo, THERAPY - Autism Spectrum Disorder (ASD) | Phase 4 | Completed | Aditi Chadha | 54 | 2017-01-01 | 2025-07-08 |
| Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults Smallpox vaccine, LISTER strain, from chick embryo cells - Smallpox, Poxvirus Infection | Phase 2 | Completed | Sanofi | 230 | 2005-09-01 | 2012-02-01 |
| Dryvax Dilution-Prev Vacc Adults Dryvax - Smallpox | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 90 | 2004-04-01 | 2010-08-27 |
| Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults ACAM2000 Smallpox Vaccine, Vaccinia virus (calf lymph) smallpox vaccine: Dryvax® - Smallpox | Phase 2 | Completed | Emergent BioSolutions | 357 | 2003-01-01 | 2024-03-18 |
| Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination Vaccinia virus: ACAM2000 smallpox vaccine, vaccinia virus (calf lymph): Dryvax - Smallpox | Phase 2 | Completed | Emergent BioSolutions | 353 | 2003-01-01 | 2024-03-18 |
| A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers Smallpox Vaccine, HIVAC-1e, gp160 Vaccine (MicroGeneSys) - HIV Infections | Phase 1 | Completed | Bristol-Myers Squibb | 2007-09-26 | ||
| Human Immune Responses Smallpox Dryvax - Smallpox | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2010-08-27 | |
| A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B) TBC-3B Vaccine, Smallpox Vaccine - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 18 | 2021-10-28 |
Smallpox (7) · Vaccinia (4) · HIV Infections (2) · Mpox, Monkeypox (2) · Autism Spectrum Disorder (1) · Cowpox (1) · Poxviridae Infections (1) · Virus Diseases (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Emergent BioSolutions (2) · Aditi Chadha (1) · Bristol-Myers Squibb (1) · Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" (1) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1) · SIGA Technologies (1) · Sanofi (1) · Washington University School of Medicine (1)
United States (8) · Chile (1) · France (1) · India (1) · Panama (1) · Peru (1) · Russia (1) · Spain (1)
Dennis Hruby, Ph.D. (1) · Keefer M (1) · Philip Mudd, MD, PhD (1) · Vladimir I. Kuzubov, PhD (1)